(Q71067446)
Statements
The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research (English)
De Lisi V
Cocconi G
Angelini F
Cavicchi F
Di Costanzo F
Gilli G
Rodinò C
Soldani M
Tonato M